GB1072118A - Amides of aminopropionic acid - Google Patents
Amides of aminopropionic acidInfo
- Publication number
- GB1072118A GB1072118A GB4679863A GB4679863A GB1072118A GB 1072118 A GB1072118 A GB 1072118A GB 4679863 A GB4679863 A GB 4679863A GB 4679863 A GB4679863 A GB 4679863A GB 1072118 A GB1072118 A GB 1072118A
- Authority
- GB
- United Kingdom
- Prior art keywords
- amide
- stearylamine
- acid
- methylation
- amidation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Paper (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Abstract
Novel basic amides are prepared by first reacting 1 to 2 mol of an ester of acrylic acid with a volatile alcohol, at a temperature below 100 DEG C. at which no substantial amidation occurs, with one mol. of primary, secondary or tertiary amine of the formula <FORM:1072118/C2/1> to form an ester-amine which is then further heated with 1 to 2 mol. of a primary, secondary or tertiary amine of the formula <FORM:1072118/C2/2> to form an amide-amine with simultaneous splitting off of an alcohol, said amide-amine being subsequently alkylated, alkoxylated and/or quaternated and/or acylated if desired, one of R1, R2 and R3 representing C12- 24 alkyl or alkenyl, each of the remaining five of R1 to R6 representing hydrogen or C1- 6 alkyl or hydroxyalkyl, A1 and A2 each representing a C2- 6 alkylene radical and each of m and n representing 0 or an integer of from 1 to 6 inclusive provided that at least one represents an integer. Examples describe the preparation of (1) a 1 :2 addition product of stearylamine and ethyl acrylate, amidation of this diester with 2 moles of 1,6-hexamethylene-diamine and either ethoxylation and quaternization, methylation, or propionylation and methylation of the resulting stearylamino-dipropionic acid di-1-aminohexyl-6-amide; (2) a 1:1 addition product of stearylamine and ethyl acrylate, amidation of this ester with 1,3-propylenediamine and either ethoxylation and quaternization, methylation or acetylation and methylation of the resulting stearylamino-propionic acid 1-aminopropyl-3-amide; (3) a 1:1 addition product of stearylamine and ethyl acrylate, amidation of this ester with 1,2-ethylenediamine and either methylation or methylation and acetylation of the resulting stearylamino-propionic acid 1-aminoethyl-2-amide; (4) a 1:1 addition product of stearylamine and ethyl acrylate, amidation of this ester with 1 mole of 1,6-hexamethylenediamine and either methylation, alkoxylation or alkoxylation and quaternization (with monochloracetic acid) of the resulting stearylamino-propionic acid 1-aminohexyl-6-amide; (5) a 1:1 addition product of stearylamine and ethyl acrylate, amidation of this ester with 1 mole of 1-amino-3-dimethylaminopropane and either methylation or carbamidomethylation (with chloroacetamide) of the resulting stearylaminopropionic acid 1-dimethylaminopropane 3-amide; (6) a 1:1 addition product of stearylamine and ethyl acrylate, amidation of this ester with 1 mole of diethylene-triamine and methylation of the resulting monostearylamino-propionic acid amide of diethylene-triamine; (7) a 1:2 addition product of stearylamine and ethyl acrylate, amidation of this diester with 2 moles of 1,3-propylene-diamine and methylation of the resulting stearylamino-dipropionic acid di-1-aminopropane-3-amide; and (8) a 1:2 addition product of stearylamine and ethyl acrylate, amidation of this diester with 2 moles of 1-amino-3-dimethylaminopropane and quaternization of the resulting stearylamino-dipropionic acid di-3-dimethylamino-propane-1- amide with either methyl sulphate or chloroacetamide.ALSO:Novel amino-amides containing a C1- 24 alkyl or alkenyl group in addition to C1- 6 alkyl or hydroxyalkyl groups (see Division C2) are alkoxylated and, if desired, further quaternated or acylated. The amino-amides and their quaternary derivatives may be used as polymerization emulsifiers. In examples a stearylamine - dipropionic acid di - 1 - aminohexyl-6-amide is ethoxylated with up to 75 mols. of ethylene oxide and subsequently quaternized with dimethyl sulphate and alternatively with chloroacetic acid; a stearylamine-propionic acid 1-aminopropyl-3-amide is ethoxylated with up to 30 mols. of ethylene oxide and subsequently quaternized with monochloroacetic acid or alternatively dimethyl sulphate, benzyl chloride, chloroacetamide, glycolchlorohydrin or epichlorohydrin; a stearylaminopropionic acid 1-aminohexyl-6-amide is propoxylated with 2.4 mols. of propylene oxide and subsequently quaternized with chloroacetic acid; a stearylamine-propionic acid 1-aminohexyl-6-amide quaternized with 2 mols. of dimethyl sulphate is added to an emulsion polymerization system containing aqueous sodium bisulphite, vinyl acetate, ferrous sulphate and hydrogen peroxide; and a stearylamine-propionic acid 1-aminopropyl-3-amide methylated with two mols. of dimethyl sulphate is added to an emulsion polymerization system containing aqueous sodium bisulphite, ethyl acrylate, butyl acrylate, acrylonitrile, ferrous sulphate and hydrogen peroxide; the polymer emulsions may be used for treating textiles or paper.ALSO:Novel amino-amides containing a C12-24 alkyl or alkenyl group in addition to C1-6 alkyl or hydroxyalkyl groups (see Division C2) and their quarternary or alkoxylated derivatives are used as levelling agents in dyeing baths or as emulsifying agents in emulsion polymerization systems, to which they impart improved paper sizing properties. In examples the products are used in a dyebath containing 2:1 metal complex dyes, ammonium sulphate, and formic acid to obtain a level dyeing effect on striped dyeing nylon woven material, and in an emulsion polymerization system containing aqueous sodium bisulphite, ferrous sulphate, hydrogen peroxide, ethylacrylate, butyl acrylate and acrylonitrile, this being used to size bleached sulphite cellulose in conjunction with rosin size, aluminium sulphate, kaolin and an optical brightening agent.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1414962 | 1962-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1072118A true GB1072118A (en) | 1967-06-14 |
Family
ID=4398397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4679863A Expired GB1072118A (en) | 1962-12-01 | 1963-11-27 | Amides of aminopropionic acid |
Country Status (3)
Country | Link |
---|---|
AT (1) | AT258875B (en) |
BE (1) | BE640639A (en) |
GB (1) | GB1072118A (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664848A (en) | 1982-12-23 | 1987-05-12 | The Procter & Gamble Company | Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties |
US8969353B2 (en) | 2008-11-07 | 2015-03-03 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US9006487B2 (en) | 2005-06-15 | 2015-04-14 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
US9181321B2 (en) | 2013-03-14 | 2015-11-10 | Shire Human Genetic Therapies, Inc. | CFTR mRNA compositions and related methods and uses |
US9193827B2 (en) | 2010-08-26 | 2015-11-24 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
US9227917B2 (en) | 2012-08-13 | 2016-01-05 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
US9308281B2 (en) | 2011-06-08 | 2016-04-12 | Shire Human Genetic Therapies, Inc. | MRNA therapy for Fabry disease |
US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
US9522176B2 (en) | 2013-10-22 | 2016-12-20 | Shire Human Genetic Therapies, Inc. | MRNA therapy for phenylketonuria |
US9629804B2 (en) | 2013-10-22 | 2017-04-25 | Shire Human Genetic Therapies, Inc. | Lipid formulations for delivery of messenger RNA |
US9840479B2 (en) | 2014-07-02 | 2017-12-12 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US9850269B2 (en) | 2014-04-25 | 2017-12-26 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US9957499B2 (en) | 2013-03-14 | 2018-05-01 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US10022455B2 (en) | 2014-05-30 | 2018-07-17 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10138213B2 (en) | 2014-06-24 | 2018-11-27 | Translate Bio, Inc. | Stereochemically enriched compositions for delivery of nucleic acids |
US10576166B2 (en) | 2009-12-01 | 2020-03-03 | Translate Bio, Inc. | Liver specific delivery of messenger RNA |
US11174500B2 (en) | 2018-08-24 | 2021-11-16 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US11173190B2 (en) | 2017-05-16 | 2021-11-16 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR |
US11224642B2 (en) | 2013-10-22 | 2022-01-18 | Translate Bio, Inc. | MRNA therapy for argininosuccinate synthetase deficiency |
US11253605B2 (en) | 2017-02-27 | 2022-02-22 | Translate Bio, Inc. | Codon-optimized CFTR MRNA |
US11254936B2 (en) | 2012-06-08 | 2022-02-22 | Translate Bio, Inc. | Nuclease resistant polynucleotides and uses thereof |
US12195505B2 (en) | 2018-11-21 | 2025-01-14 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR |
-
1963
- 1963-11-27 GB GB4679863A patent/GB1072118A/en not_active Expired
- 1963-11-29 AT AT956163A patent/AT258875B/en active
- 1963-11-29 BE BE640639A patent/BE640639A/xx unknown
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664848A (en) | 1982-12-23 | 1987-05-12 | The Procter & Gamble Company | Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties |
US9006487B2 (en) | 2005-06-15 | 2015-04-14 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
US8969353B2 (en) | 2008-11-07 | 2015-03-03 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US11414393B2 (en) | 2008-11-07 | 2022-08-16 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US10844028B2 (en) | 2008-11-07 | 2020-11-24 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US10189802B2 (en) | 2008-11-07 | 2019-01-29 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US9556110B2 (en) | 2008-11-07 | 2017-01-31 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
US10576166B2 (en) | 2009-12-01 | 2020-03-03 | Translate Bio, Inc. | Liver specific delivery of messenger RNA |
US9193827B2 (en) | 2010-08-26 | 2015-11-24 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
US10117934B2 (en) | 2011-03-28 | 2018-11-06 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
US10933139B2 (en) | 2011-03-28 | 2021-03-02 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
US11338044B2 (en) | 2011-06-08 | 2022-05-24 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US10238754B2 (en) | 2011-06-08 | 2019-03-26 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for MRNA delivery |
US12121592B2 (en) | 2011-06-08 | 2024-10-22 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11951180B2 (en) | 2011-06-08 | 2024-04-09 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for MRNA delivery |
US11951181B2 (en) | 2011-06-08 | 2024-04-09 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11951179B2 (en) | 2011-06-08 | 2024-04-09 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for MRNA delivery |
US11730825B2 (en) | 2011-06-08 | 2023-08-22 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11547764B2 (en) | 2011-06-08 | 2023-01-10 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for MRNA delivery |
US9597413B2 (en) | 2011-06-08 | 2017-03-21 | Shire Human Genetic Therapies, Inc. | Pulmonary delivery of mRNA |
US10413618B2 (en) | 2011-06-08 | 2019-09-17 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11291734B2 (en) | 2011-06-08 | 2022-04-05 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US10350303B1 (en) | 2011-06-08 | 2019-07-16 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11185595B2 (en) | 2011-06-08 | 2021-11-30 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US10507249B2 (en) | 2011-06-08 | 2019-12-17 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11052159B2 (en) | 2011-06-08 | 2021-07-06 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US9308281B2 (en) | 2011-06-08 | 2016-04-12 | Shire Human Genetic Therapies, Inc. | MRNA therapy for Fabry disease |
US10888626B2 (en) | 2011-06-08 | 2021-01-12 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
US11254936B2 (en) | 2012-06-08 | 2022-02-22 | Translate Bio, Inc. | Nuclease resistant polynucleotides and uses thereof |
US9227917B2 (en) | 2012-08-13 | 2016-01-05 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
US9439968B2 (en) | 2012-08-13 | 2016-09-13 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
US11510937B2 (en) | 2013-03-14 | 2022-11-29 | Translate Bio, Inc. | CFTR MRNA compositions and related methods and uses |
US11820977B2 (en) | 2013-03-14 | 2023-11-21 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US9181321B2 (en) | 2013-03-14 | 2015-11-10 | Shire Human Genetic Therapies, Inc. | CFTR mRNA compositions and related methods and uses |
US10420791B2 (en) | 2013-03-14 | 2019-09-24 | Translate Bio, Inc. | CFTR MRNA compositions and related methods and uses |
US10876104B2 (en) | 2013-03-14 | 2020-12-29 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US9713626B2 (en) | 2013-03-14 | 2017-07-25 | Rana Therapeutics, Inc. | CFTR mRNA compositions and related methods and uses |
US9957499B2 (en) | 2013-03-14 | 2018-05-01 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US11692189B2 (en) | 2013-03-14 | 2023-07-04 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
US10959953B2 (en) | 2013-10-22 | 2021-03-30 | Translate Bio, Inc. | Lipid formulations for delivery of messenger RNA |
US9522176B2 (en) | 2013-10-22 | 2016-12-20 | Shire Human Genetic Therapies, Inc. | MRNA therapy for phenylketonuria |
US11890377B2 (en) | 2013-10-22 | 2024-02-06 | Translate Bio, Inc. | Lipid formulations for delivery of messenger RNA |
US10052284B2 (en) | 2013-10-22 | 2018-08-21 | Translate Bio, Inc. | Lipid formulations for delivery of messenger RNA |
US9629804B2 (en) | 2013-10-22 | 2017-04-25 | Shire Human Genetic Therapies, Inc. | Lipid formulations for delivery of messenger RNA |
US10493031B2 (en) | 2013-10-22 | 2019-12-03 | Translate Bio, Inc. | Lipid formulations for delivery of messenger RNA |
US10208295B2 (en) | 2013-10-22 | 2019-02-19 | Translate Bio, Inc. | MRNA therapy for phenylketonuria |
US11224642B2 (en) | 2013-10-22 | 2022-01-18 | Translate Bio, Inc. | MRNA therapy for argininosuccinate synthetase deficiency |
US11377642B2 (en) | 2013-10-22 | 2022-07-05 | Translate Bio, Inc. | mRNA therapy for phenylketonuria |
US10155785B2 (en) | 2014-04-25 | 2018-12-18 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US11059841B2 (en) | 2014-04-25 | 2021-07-13 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US12060381B2 (en) | 2014-04-25 | 2024-08-13 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US9850269B2 (en) | 2014-04-25 | 2017-12-26 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US11884692B2 (en) | 2014-04-25 | 2024-01-30 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US10022455B2 (en) | 2014-05-30 | 2018-07-17 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10286082B2 (en) | 2014-05-30 | 2019-05-14 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10293057B2 (en) | 2014-05-30 | 2019-05-21 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US11433144B2 (en) | 2014-05-30 | 2022-09-06 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10493166B2 (en) | 2014-05-30 | 2019-12-03 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10286083B2 (en) | 2014-05-30 | 2019-05-14 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10912844B2 (en) | 2014-05-30 | 2021-02-09 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
US10138213B2 (en) | 2014-06-24 | 2018-11-27 | Translate Bio, Inc. | Stereochemically enriched compositions for delivery of nucleic acids |
US11104652B2 (en) | 2014-06-24 | 2021-08-31 | Translate Bio, Inc. | Stereochemically enriched compositions for delivery of nucleic acids |
US9840479B2 (en) | 2014-07-02 | 2017-12-12 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US11253605B2 (en) | 2017-02-27 | 2022-02-22 | Translate Bio, Inc. | Codon-optimized CFTR MRNA |
US11173190B2 (en) | 2017-05-16 | 2021-11-16 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR |
US11174500B2 (en) | 2018-08-24 | 2021-11-16 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US12084702B2 (en) | 2018-08-24 | 2024-09-10 | Translate Bio, Inc. | Methods for purification of messenger RNA |
US12195505B2 (en) | 2018-11-21 | 2025-01-14 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR |
Also Published As
Publication number | Publication date |
---|---|
AT258875B (en) | 1967-12-11 |
BE640639A (en) | 1964-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1072118A (en) | Amides of aminopropionic acid | |
GB1015795A (en) | Cation-active copolymers | |
KR950003851B1 (en) | Mono-ester as fiber and fabric treatment composition | |
KR870011326A (en) | Printing or dyeing of cellulose-containing textile materials | |
US5674832A (en) | Cationic compositions containing diol and/or diol alkoxylate | |
US5718891A (en) | Process for the production of solid esterquats with improved dispersibility in water | |
US5389136A (en) | Wax dispersions, their production and use | |
US4386965A (en) | Process for obtaining coating compositions of improved whiteness | |
GB1152947A (en) | Hydroxyalkyl Quaternary Ammonium Ethers as Antistatic Agents | |
US4605511A (en) | Stable stilbene fluorescent brightener solution | |
US4540521A (en) | Liquid quaternary ammonium antistatic compositions | |
GB818362A (en) | Detergent preparations for the hair | |
JP4200476B2 (en) | Soft tissue softener for home tissue, paper making method using the same, and soft tissue paper for home use | |
US4118324A (en) | Fabric softeners | |
GB1124538A (en) | Novel fluorocarbon derivatives useful as oil-repellency agents | |
ES509979A0 (en) | A PROCEDURE FOR PREPARING AN AQUEOUS COMPOSITION FOR TREATMENT OF TEXTILE MATERIALS. | |
FI852240A0 (en) | POLYURETANLATEX, SOM KAN ANVAENDAS SOM LIMAEMNE I PAPPERSINDUSTRIN, OCH FOERFARANDE FOER FRAMSTAELLNING AV DETTA. | |
US4122018A (en) | Smoothing agents for treating textile fiber material | |
KR850008508A (en) | How to dye or print cellulose blend fiber material with bat dye | |
KR910000586A (en) | Styrene oxide products | |
US4001285A (en) | Amidopolyaminesulfonates | |
KR890006913A (en) | Method for dyeing natural polyamide fibers using reactive dyes | |
GB1020142A (en) | Process for the production of non-woven fabrics | |
GB810352A (en) | Improvements in minimising the electrostatic charge of undyed fibres, threads or fabrics | |
KR850005525A (en) | Printing method of cellulose-containing fiber material |